D.A. DAVIDSON & CO. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 23 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$8,293
+21.1%
66,5000.0%0.00%
Q4 2022$6,850
-31.5%
66,5000.0%0.00%
Q3 2022$10,000
-90.0%
66,500
-41.7%
0.00%
-100.0%
Q2 2022$100,000
-36.7%
114,000
-10.6%
0.00%
-50.0%
Q1 2022$158,000
-36.5%
127,5000.0%0.00%
-33.3%
Q4 2021$249,000
-28.7%
127,5000.0%0.00%
-25.0%
Q3 2021$349,000
-15.7%
127,500
-3.0%
0.00%
-20.0%
Q2 2021$414,000
+45.8%
131,500
-1.5%
0.01%
+25.0%
Q1 2021$284,000
+6.4%
133,500
-2.9%
0.00%0.0%
Q4 2020$267,000
+178.1%
137,5000.0%0.00%
+100.0%
Q3 2020$96,000
+11.6%
137,500
-16.2%
0.00%0.0%
Q2 2020$86,000
+79.2%
164,000
+49.1%
0.00%
+100.0%
Q1 2020$48,000
-36.8%
110,0000.0%0.00%0.0%
Q4 2019$76,000
-32.1%
110,000
+4.8%
0.00%
-50.0%
Q3 2019$112,000
+86.7%
105,000
+27.3%
0.00%
+100.0%
Q2 2019$60,000
-59.2%
82,500
-27.9%
0.00%
-66.7%
Q1 2019$147,000
+4.3%
114,500
+21.8%
0.00%0.0%
Q4 2018$141,000
+27.0%
94,000
+22.9%
0.00%
+50.0%
Q3 2018$111,000
+5.7%
76,5000.0%0.00%0.0%
Q2 2018$105,000
+110.0%
76,500
+43.0%
0.00%
+100.0%
Q1 2018$50,000
-54.1%
53,500
-45.7%
0.00%
-50.0%
Q4 2017$109,000
-30.6%
98,5000.0%0.00%
-33.3%
Q3 2017$157,000
-14.7%
98,5000.0%0.00%
-25.0%
Q2 2017$184,000
+3.4%
98,500
+8.2%
0.00%0.0%
Q1 2017$178,000
-45.1%
91,000
+4.6%
0.00%
-42.9%
Q4 2016$324,000
+157.1%
87,000
+190.0%
0.01%
+133.3%
Q3 2016$126,00030,0000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Performa Ltd (US), LLC 4,900$9,1630.01%
View complete list of VISTAGEN THERAPEUTICS INC shareholders